BlackRock Investment Management, LLC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q4 2016$10,0000.0%1,9000.0%0.00%
Q3 2016$10,000
+11.1%
1,9000.0%0.00%
Q2 2016$9,0000.0%1,9000.0%0.00%
Q1 2016$9,000
-10.0%
1,9000.0%0.00%
Q4 2015$10,0000.0%1,900
+9.0%
0.00%
Q3 2015$10,000
-16.7%
1,7430.0%0.00%
Q2 2015$12,000
-7.7%
1,743
-9.9%
0.00%
Q1 2015$13,000
+8.3%
1,9350.0%0.00%
Q4 2014$12,000
+20.0%
1,9350.0%0.00%
Q3 2014$10,000
+25.0%
1,935
+12.9%
0.00%
Q2 2014$8,0001,7140.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q2 2015
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders